Immunome (IMNM) Other Working Capital Changes (2019 - 2026)
Immunome's (IMNM) quarterly Other Working Capital Changes came in at $6.8 million in Q4 2025, up 176.14% YoY from $2.5 million in Q4 2024, and up 268.74% on a QoQ basis from -$4.0 million in Q2 2025.
Immunome (IMNM) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 4 years of Other Working Capital Changes data on file, last reported at $6.8 million in Q4 2025.
- Quarterly Other Working Capital Changes rose 176.14% year-over-year to $6.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 123.11% YoY) and the FY2025 annual result came in at -$166000.0, up 98.16% from the prior year.
- Other Working Capital Changes climbed to $6.8 million in Q4 2025, from -$4.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.7 million in Q4 2023 to a low of -$4.0 million in Q1 2022.
- A 5-year average of $397294.1 and a median of -$214000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 153633.33% in 2023, down 18434.78% in 2023.
- Tracing IMNM's Other Working Capital Changes over 4 years: stood at -$157000.0 in 2022, then plunged by 12419.11% to -$19.7 million in 2023, then soared by 54.73% to -$8.9 million in 2024, then surged by 176.14% to $6.8 million in 2025.
- The last three Other Working Capital Changes figures came in at $6.8 million (Q4 2025), -$4.0 million (Q2 2025), and -$2.9 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.90 Mn |
| Jun 30, 2026 | 6.90 Mn |
| Jun 30, 2026 | 6.90 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |